Norway Oligonucleotide Synthesis Market Size & Outlook
Norway oligonucleotide synthesis market, 2018-2030 (US$M)
Related Markets
Norway oligonucleotide synthesis market highlights
- The Norway oligonucleotide synthesis market generated a revenue of USD 38.0 million in 2024 and is expected to reach USD 63.0 million by 2030.
- The Norway market is expected to grow at a CAGR of 8.8% from 2025 to 2030.
- In terms of segment, services was the largest revenue generating segment in 2024.
- Services is the most lucrative segment segment registering the fastest growth during the forecast period.
Oligonucleotide synthesis market data book summary
| Market revenue in 2024 | USD 38.0 million |
| Market revenue in 2030 | USD 63.0 million |
| Growth rate | 8.8% (CAGR from 2024 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
Other key industry trends
- In terms of revenue, Norway accounted for 0.9% of the global oligonucleotide synthesis market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany oligonucleotide synthesis market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 529.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oligonucleotide Synthesis Market Scope
Oligonucleotide Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway oligonucleotide synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 37.89% in 2024. Horizon Databook has segmented the Norway oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
The oligonucleotide synthesis market in Norway is expected to witness steady growth over the forecast period. Growth can be attributed to the advancements in research, expanding applications, and increasing awareness of personalized medicine. Companies that navigate the challenges, adapt to the evolving landscape and develop strategic partnerships.
In addition, the growing prevalence of lung cancer in the country is expected to support market growth over the forecast period. Oligonucleotide synthesis, the process of creating short single-stranded DNA or RNA molecules, has the potential for lung cancer diagnosis, treatment, and prevention. Norway has a high prevalence of lung cancer cases.
Reasons to subscribe to Norway oligonucleotide synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway oligonucleotide synthesis market databook
-
Our clientele includes a mix of oligonucleotide synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into Norway oligonucleotide synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway oligonucleotide synthesis market size, by segment, 2018-2030 (US$M)
Norway Oligonucleotide Synthesis Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
